Xue-Jun Song Selected Research

Eph Family Receptors (Eph Receptors)

1/2020	Activation of EphB receptors contributes to primary sensory neuron excitability by facilitating Ca2+ influx directly or through Src kinase-mediated N-methyl-D-aspartate receptor phosphorylation.
12/2013	EphrinB-EphB receptor signaling contributes to bone cancer pain via Toll-like receptor and proinflammatory cytokines in rat spinal cord.
1/2009	EphB receptor signaling in mouse spinal cord contributes to physical dependence on morphine.
11/2008	Targeted mutation of EphB1 receptor prevents development of neuropathic hyperalgesia and physical dependence on morphine in mice.
11/2008	Upregulation and redistribution of ephrinB and EphB receptor in dorsal root ganglion and spinal dorsal horn neurons after peripheral nerve injury and dorsal rhizotomy.
9/2008	EphrinB-EphB receptor signaling contributes to neuropathic pain by regulating neural excitability and spinal synaptic plasticity in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xue-Jun Song Research Topics

Disease

26	Hyperalgesia 05/2022 - 04/2003
23	Pain (Aches) 05/2022 - 03/2005
15	Neuralgia (Stump Neuralgia) 06/2022 - 03/2005
8	Bone Neoplasms (Bone Cancer) 01/2021 - 07/2011
8	Inflammation (Inflammations) 01/2020 - 03/2005
7	Peripheral Nerve Injuries 01/2020 - 05/2005
3	Diabetic Neuropathies (Diabetic Neuropathy) 06/2022 - 10/2021
3	Hypersensitivity (Allergy) 06/2022 - 09/2008
3	Cancer Pain 01/2021 - 01/2015
3	Chronic Pain 01/2020 - 02/2009
3	Neoplasms (Cancer) 08/2019 - 08/2014
3	Ganglion Cysts (Ganglion) 10/2012 - 09/2003
3	Opioid-Related Disorders (Opiate Addiction) 06/2010 - 11/2008
2	COVID-19 01/2021 - 11/2020
2	Morphine Dependence 06/2010 - 11/2008
1	Demyelinating Diseases (Demyelinating Disease) 10/2021
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2020
1	Spinal Cord Ischemia 10/2017
1	Postoperative Pain 01/2016
1	Fatigue 01/2015
1	Nausea 01/2015
1	Constipation 01/2015
1	Anorexia 01/2015
1	Insulin Resistance 04/2014
1	Body Weight (Weight, Body) 04/2014

Drug/Important Bio-Agent (IBA)

8	Analgesics (Analgesic Drugs)IBA 01/2022 - 03/2005
6	CytokinesIBA 01/2021 - 12/2013
6	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2020 - 04/2003
6	Eph Family Receptors (Eph Receptors)IBA 01/2020 - 09/2008
6	Morphine (MS Contin)FDA LinkGeneric 01/2020 - 11/2008
5	Vitamin B Complex (B Vitamins)IBA 10/2021 - 03/2005
5	Proteins (Proteins, Gene)FDA Link 08/2019 - 10/2008
4	Phosphotransferases (Kinase)IBA 01/2020 - 09/2008
4	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 08/2014 - 01/2006
4	EphB1 ReceptorIBA 12/2013 - 11/2008
4	Indicators and Reagents (Reagents)IBA 07/2011 - 09/2008
3	Tyrosine (L-Tyrosine)FDA Link 01/2020 - 09/2008
3	CateninsIBA 01/2016 - 05/2013
3	Adenosine Monophosphate (AMP)IBA 08/2014 - 11/2011
3	SodiumIBA 04/2014 - 05/2008
2	Blood Glucose (Blood Sugar)IBA 06/2022 - 04/2014
2	Streptozocin (Streptozotocin)FDA Link 06/2022 - 10/2021
2	Peptides (Polypeptides)IBA 01/2022 - 07/2012
2	GelatinasesIBA 10/2021 - 06/2010
2	Ion Channels (Ion Channel)IBA 01/2021 - 08/2019
2	Opioid Analgesics (Opioids)IBA 01/2020 - 06/2010
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2016 - 01/2006
2	Hematoxylin (Haematoxylon)IBA 01/2016 - 01/2006
2	salicylhydroxamic acid (SHAM)IBA 08/2014 - 09/2003
2	Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA 04/2014 - 11/2011
2	Thiamine (Aneurin)FDA Link 02/2009 - 03/2005
2	Cyclic GMP-Dependent Protein Kinases (Protein Kinase G)IBA 01/2007 - 01/2006
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 06/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 06/2022
1	Colchicine FDA LinkGeneric 05/2022
1	verubecestatIBA 01/2022
1	Amyloid beta-PeptidesIBA 01/2022
1	Matrix Metalloproteinases (MMPs)IBA 10/2021
1	Thioctic Acid (Lipoic Acid)IBA 10/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	InterferonsIBA 07/2020
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 01/2020
1	Naloxone (Narcan)FDA LinkGeneric 01/2020
1	Opioid Receptors (Opioid Receptor)IBA 01/2020
1	Freund's AdjuvantIBA 01/2020
1	src-Family KinasesIBA 01/2020
1	erythromycin propionate-N-acetylcysteinateIBA 08/2019
1	Cyclic NucleotidesIBA 08/2019
1	Opiate AlkaloidsIBA 10/2017
1	EnzymesIBA 01/2016
1	InterleukinsIBA 01/2016
1	ImmunosorbentsIBA 01/2016
1	Interleukin-10 (Interleukin 10)IBA 01/2016
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2016
1	lysophosphatidic acidIBA 01/2016
1	adenosine-3',5'-cyclic phosphorothioateIBA 08/2014
1	protein kinase modulatorIBA 08/2014
1	Glucose (Dextrose)FDA LinkGeneric 04/2014
1	Insulin (Novolin)FDA Link 04/2014
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 04/2014
1	SugarsIBA 04/2014
1	Toll-Like Receptors (Toll-Like Receptor)IBA 12/2013
1	8-(4-chlorophenylthio)guanosine 3',5'-cyclic monophosphorothioateIBA 10/2012
1	Adenylyl Cyclases (Adenylyl Cyclase)IBA 07/2012
1	PAR-2 ReceptorIBA 07/2012
1	TrypsinIBA 07/2012

Therapy/Procedure

3	Therapeutics 10/2021 - 03/2005
2	Rhizotomy 05/2022 - 11/2008
2	Pain Management 01/2021 - 11/2020
2	Radiotherapy 08/2019 - 01/2016
2	Musculoskeletal Manipulations (Manipulative Therapy) 01/2016 - 01/2006
2	Spinal Manipulation 01/2016 - 01/2006
2	Intraperitoneal Injections 04/2014 - 03/2005
1	Transplantation 06/2022
1	Drug Therapy (Chemotherapy) 06/2022
1	Immunomodulation 07/2020
1	Decompression 01/2016
1	Oral Administration 01/2015
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2015
1	Aftercare (After-Treatment) 01/2015